This finding suggests that mesenchymal cells with dysregulated SAA metabolism are under stress already in regular growth conditions, and are not responsive to cellular stress induced by methionine/cystine restriction
Lean mass preservation is an emerging differentiator in next-gen compounds
Patients with wasting diseases (most famously HIV/AIDS) Patients with lung cancer and other pulmonary diseases Patients with major injuries, sepsis, and trauma Patients with gut diseases like Inflammatory Bowel Disease (Crohns Disease and ulcerative colitis) Patients with Chronic Fatigue Syndrome Overtrained athletes People with alcoholism or fatty liver disease People with diabetes and lower glucose tolerance In many of these cases, raising glutathione levels has shown some therapeutic benefits
Tirzepatide's mechanismGLP-1/GIP receptor agonismis distinct from B-vitamin metabolism
Table 4 Multivariable linear regression analysis for changes in body weight 12 months after GLP-1 receptor agonist initiation
This is significant for men who may have prediabetic tendencies or insulin resistance, as many GH-based therapies can temporarily worsen glucose control
